INFLUENCE OF COMORBIDITY ON CLINICAL CRITERIA FOR CONTROL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Article Sidebar

PDF (Русский)
Issue: Vol. 5 No. 1 : Eurasian Journal of Medical and Natural Sciences
Section: Articles
Published:
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Main Article Content

Central Asian Medical University.
sanjar20140327@gmail.com

Abstract:

Chronic obstructive pulmonary disease (COPD) often coexists with other chronic diseases, namely comorbidities. They negatively affect the prognosis, exacerbations and quality of life of patients with COPD. However, no studies have been conducted to examine the impact of these comorbidities on the clinical control criteria of COPD.

Keywords:

Article Details

How to Cite:

Косимов, С. . (2025). INFLUENCE OF COMORBIDITY ON CLINICAL CRITERIA FOR CONTROL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Eurasian Journal of Medical and Natural Sciences, 5(1), 271–274. Retrieved from https://in-academy.uz/index.php/EJMNS/article/view/44106

References:

Тарловская Е.И. Коморбидность и полиморбидность - современная трактовка и насущные задачи, стоящие перед терапевтическим сообществом. Кардиология. 2018;58(S9):29-38. https://doi.org/10.18087/cardio.2562.

Верткин А. Л. Коморбидность: история, современное представление, профилактика и лечение. Кардиоваскулярная терапия и профилактика. 2015;14(2):74-9. https://doi.org/10.15829/1728-8800-2015-2-74-79.

Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2015;5(2):020415. https://doi.org/10.7189/jogh.05-020415.

GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691-706. https://doi.org/10.1016/S2213-2600(17)30293-X.

Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631-9. https://doi.org/10.1016/S2213-2600(15)00241-6.

Cazzola M, Rogliani P, Matera MG. Cardiovascular disease in patients with COPD. Lancet Respir Med. 2015;3(8):593-5. https://doi.org/10.1016/S2213-2600(15)00279-9.

Roversi S, Fabbri LM, Sin DD, et al. Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care. Am J Respir Crit Care Med. 2016;194(11):1319-36. https://doi.org/10.1164/rccm.201604-0690SO.

Григорьева Н. Ю., Майорова М. В., Королёва М. Е., Самолюк М. О. Особенности формирования и развития сердечно-сосудистых заболеваний у больных хронической обструктивной болезнью легких. Терапевтический архив. 2019;91(1):16-47. https://doi.org/10.26442/00403660.2019.01.000027.

Lahousse L, Tiemeier H, Ikram MA, Brusselle GG. Chronic obstructive pulmonary disease and cerebrovascular disease: A comprehensive review. Respir Med. 2015;109(11):1371-80. https://doi.org/10.1016/j.rmed.2015.07.014.

Morgan AD, Sharma C, Rothnie KJ, et al. Chronic Obstructive Pulmonary Disease and the Risk of Stroke. Ann Am Thorac Soc. 2017;14(5):754-65. https://doi.org/10.1513/AnnalsATS.201611-932SR.